InvestorsObserver
×
News Home

Analyst Rating: Will Mustang Bio Inc (MBIO) Stock Do Better Than the Market?

Friday, October 15, 2021 11:43 AM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Mustang Bio Inc (MBIO) Stock Do Better Than the Market?

InvestorsObserver is giving Mustang Bio Inc (MBIO) an Analyst Rating Rank of 75, meaning MBIO is ranked higher by analysts than 75% of stocks. The average price target for MBIO is $10.4 and analyst’s rate the stock as a Strong Buy.

Overall Score - 5
Wall Street analysts are rating MBIO a Strong Buy today. Find out what this means to you and get the rest of the rankings on MBIO!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Mustang Bio Inc Stock Today?

Mustang Bio Inc (MBIO) stock has fallen -1.29% while the S&P 500 is up 0.63% as of 11:42 AM on Friday, Oct 15. MBIO has fallen -$0.03 from the previous closing price of $2.32 on volume of 191,490 shares. Over the past year the S&P 500 is up 28.22% while MBIO has fallen -28.44%. MBIO lost -$0.89 per share the over the last 12 months. Click Here to get the full Stock Report for Mustang Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App